Targeted Therapy in Pediatric Low-Grade Glioma |
| |
Authors: | John-Paul Kilday Ute Katharina Bartels Eric Bouffet |
| |
Institution: | 1. Department of Haematology/Oncology, Royal Manchester Children’s Hospital, Oxford Road, Manchester, M13 9WL, UK 2. Division of Haematology/Oncology, Hospital for Sick Children, University of Toronto, Toronto, ON, M5G 1X8, Canada
|
| |
Abstract: | Collectively, pediatric low-grade gliomas account for most brain tumors reported in children. Surgery is typically curable for operable lesions. However, more effective therapies are required for inaccessible tumors, both to overcome refractory disease and to minimize the toxicity associated with conventional adjuvant chemotherapy and radiotherapy regimens. Recent years have witnessed rapid improvements in our understanding of the molecular pathogenesis of several childhood tumors, including low-grade gliomas. As a result, several novel compounds targeting and inhibiting critical components of molecular signaling pathways purported to be overactive in the disease have been developed. This article summarizes the most recent literature evaluating such novel targeted agents in childhood low-grade gliomas. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|